The use of growth factors with antibiotics in the setting of neutropenic fever

American Journal of Medicine

Volumn 100, Issue 1, 1996, Pages 15-16

  Hussein, Atif M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; NETILMICIN; TIMENTIN;

ANTIBIOTIC THERAPY; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CLINICAL TRIAL; COST BENEFIT ANALYSIS; EDITORIAL; FEVER; GRANULOCYTOPENIA; HEMATOPOIETIC STEM CELL; HUMAN; NEUTROPENIA; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 0030050734     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)90005-4     Document Type: Article

References (2)

1. Peters WP. High-dose chemotherapy and autologous bone marrow support for breast cancer. In: DeVita VT, Hellman S, Rosenberg SA, eds. Important Advances in Oncology. Philadelphia: Lippincott; 1991:135-150.
2. Crawford J, Ozer H, Stoller R, et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. NEJM. 1991;325:164-170.